Thomas Finser
Hedge fund manager, deep value, small-cap, family office

LCA-Vision Q3 Update

Shares of laser vision correction specialist LCA-Vision (NASDAQ:LCAV) remain largely unchanged since the 4/25/13 release of LCA-Vision: The Case For Calculated Optimism. In the following overview, I will briefly recap the past six months and provide a progress reports to the LCAV long-term recovery thesis.

Q3 Earnings Highlights

  • Revenues increased +3.2%. Procedure volume +3.7% to 11,932 in Q3. This is the first YOY volume increase in 5 quarters. YTD revenue of $71m and procedure volume of 41,198 remain depressed YOY due to tough 1H comps (FSA reductions). Q3 net loss of $1.6m, an improvement from a loss of $3.5m in 2012.
  • Average revenue per procedure of $1,718, slightly higher than expected.
  • Balance Sheet: Their financial
Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
IDEA GENERATORXExclusive access to 10 PRO ideas every day
INVESTING IDEAS LIBRARYXExclusive access to PRO library of more than 15,000 ideas
SECTOR EXPERT NETWORKXExclusive access to all sector experts for direct consultation
PERFORMANCE TRACKINGXTrack performance of all PRO stock ideas
PROFESSIONAL TOOLSXProfessional Idea Filters to zero-in based on industry, market cap and more
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO."Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else."Patrick Rice, Mainstay Capital Management
You may cancel at any time for any reason, and receive a prompt refund for membership on months paid and not used (max. 6 months). Details